InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,176.80
(
-0.11%
)
Dow Jones
39,806.77
(
-0.49%
)
Brent Oil
82.48
(
-1.26%
)
Bitcoin
71,038.18
(
-0.58%
)
Post# of 14684
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Solar_Express

Send PM Follow Ignore
Followers 73
Posts 10908
Boards Moderated 1
Alias Born 10/02/2009

Solar_Express

Re: None

Sunday, 03/22/2020 2:06:06 PM

Sunday, March 22, 2020 2:06:06 PM

Post# of 14684
Generex’s Ii-Key peptide vaccines for infectious disease and cancer have been studied in human clinical trials involving over 300 subjects in Phase I and Phase II clinical trials
See publications at https://generex.com/covid-19
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up